nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Levofloxacin—CYP3A4—bone cancer	0.0044	0.36	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.00425	0.348	CrCbGaD
Gatifloxacin—Norfloxacin—CYP3A4—bone cancer	0.00357	0.292	CrCbGaD
Gatifloxacin—Ataxia—Methotrexate—bone cancer	0.00291	0.00295	CcSEcCtD
Gatifloxacin—Renal failure acute—Doxorubicin—bone cancer	0.0029	0.00294	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.0029	0.00293	CcSEcCtD
Gatifloxacin—Myalgia—Cisplatin—bone cancer	0.00289	0.00293	CcSEcCtD
Gatifloxacin—Anxiety—Cisplatin—bone cancer	0.00288	0.00292	CcSEcCtD
Gatifloxacin—Migraine—Epirubicin—bone cancer	0.00285	0.00289	CcSEcCtD
Gatifloxacin—Renal impairment—Doxorubicin—bone cancer	0.00282	0.00285	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Doxorubicin—bone cancer	0.0028	0.00284	CcSEcCtD
Gatifloxacin—Face oedema—Epirubicin—bone cancer	0.0028	0.00283	CcSEcCtD
Gatifloxacin—Oedema—Cisplatin—bone cancer	0.00277	0.00281	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Cisplatin—bone cancer	0.00277	0.00281	CcSEcCtD
Gatifloxacin—Infection—Cisplatin—bone cancer	0.00275	0.00279	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Doxorubicin—bone cancer	0.00275	0.00278	CcSEcCtD
Gatifloxacin—Ataxia—Epirubicin—bone cancer	0.00272	0.00276	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Cisplatin—bone cancer	0.00271	0.00275	CcSEcCtD
Gatifloxacin—Tachycardia—Cisplatin—bone cancer	0.00271	0.00274	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00268	0.00271	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Cisplatin—bone cancer	0.00268	0.00271	CcSEcCtD
Gatifloxacin—Asthma—Methotrexate—bone cancer	0.00267	0.00271	CcSEcCtD
Gatifloxacin—Dry skin—Epirubicin—bone cancer	0.00265	0.00269	CcSEcCtD
Gatifloxacin—Anorexia—Cisplatin—bone cancer	0.00264	0.00267	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—bone cancer	0.00264	0.00267	CcSEcCtD
Gatifloxacin—Pancreatitis—Methotrexate—bone cancer	0.00262	0.00265	CcSEcCtD
Gatifloxacin—Hypotension—Cisplatin—bone cancer	0.00259	0.00262	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—bone cancer	0.00259	0.00262	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—bone cancer	0.00259	0.00262	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—bone cancer	0.00256	0.00259	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00255	0.00259	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—bone cancer	0.00255	0.00259	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00253	0.00256	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—bone cancer	0.00252	0.00255	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—bone cancer	0.0025	0.00253	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—bone cancer	0.0025	0.00253	CcSEcCtD
Gatifloxacin—Neutropenia—Methotrexate—bone cancer	0.0025	0.00253	CcSEcCtD
Gatifloxacin—Dysuria—Methotrexate—bone cancer	0.0025	0.00253	CcSEcCtD
Gatifloxacin—Paraesthesia—Cisplatin—bone cancer	0.00249	0.00252	CcSEcCtD
Gatifloxacin—Dyspnoea—Cisplatin—bone cancer	0.00247	0.0025	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—bone cancer	0.00246	0.00249	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—bone cancer	0.00245	0.00248	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Methotrexate—bone cancer	0.00244	0.00247	CcSEcCtD
Gatifloxacin—Decreased appetite—Cisplatin—bone cancer	0.00241	0.00244	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—bone cancer	0.0024	0.00243	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—bone cancer	0.00237	0.0024	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00236	0.00239	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—bone cancer	0.00236	0.00239	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00236	0.00239	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—bone cancer	0.00234	0.00237	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—bone cancer	0.00234	0.00237	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—bone cancer	0.00232	0.00235	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—bone cancer	0.00232	0.00235	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—bone cancer	0.00232	0.00234	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—bone cancer	0.00232	0.00234	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—bone cancer	0.00229	0.00231	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—bone cancer	0.00228	0.00231	CcSEcCtD
Gatifloxacin—Feeling abnormal—Cisplatin—bone cancer	0.00228	0.00231	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—bone cancer	0.00227	0.0023	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—bone cancer	0.00227	0.0023	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—bone cancer	0.00226	0.00229	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—bone cancer	0.00225	0.00228	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00221	0.00224	CcSEcCtD
Gatifloxacin—Body temperature increased—Cisplatin—bone cancer	0.00219	0.00222	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—bone cancer	0.00218	0.0022	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—bone cancer	0.00217	0.0022	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—bone cancer	0.00217	0.00219	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—bone cancer	0.00217	0.00219	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—bone cancer	0.00214	0.00217	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—bone cancer	0.00214	0.00217	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—bone cancer	0.00213	0.00215	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—bone cancer	0.00212	0.00215	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—bone cancer	0.00211	0.00214	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—bone cancer	0.00211	0.00213	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—bone cancer	0.00209	0.00212	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—bone cancer	0.00206	0.00209	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00205	0.00207	CcSEcCtD
Gatifloxacin—Hypersensitivity—Cisplatin—bone cancer	0.00204	0.00207	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—bone cancer	0.00204	0.00206	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—bone cancer	0.00202	0.00205	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—bone cancer	0.00201	0.00204	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.00201	0.00203	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—bone cancer	0.002	0.00203	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—bone cancer	0.002	0.00203	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—bone cancer	0.002	0.00202	CcSEcCtD
Gatifloxacin—Asthenia—Cisplatin—bone cancer	0.00199	0.00201	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—bone cancer	0.00199	0.00201	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—bone cancer	0.00198	0.002	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—bone cancer	0.00197	0.002	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—bone cancer	0.00197	0.00199	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—bone cancer	0.00195	0.00197	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—bone cancer	0.00193	0.00195	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—bone cancer	0.00192	0.00194	CcSEcCtD
Gatifloxacin—Diarrhoea—Cisplatin—bone cancer	0.0019	0.00192	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—bone cancer	0.00189	0.00192	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—bone cancer	0.00187	0.0019	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—bone cancer	0.00187	0.00189	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—bone cancer	0.00186	0.00189	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—bone cancer	0.00185	0.00188	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—bone cancer	0.00184	0.00186	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—bone cancer	0.00183	0.00185	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—bone cancer	0.00183	0.00185	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—bone cancer	0.0018	0.00183	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—bone cancer	0.00179	0.00181	CcSEcCtD
Gatifloxacin—Vomiting—Cisplatin—bone cancer	0.00176	0.00178	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—bone cancer	0.00176	0.00178	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—bone cancer	0.00175	0.00177	CcSEcCtD
Gatifloxacin—Rash—Cisplatin—bone cancer	0.00175	0.00177	CcSEcCtD
Gatifloxacin—Dermatitis—Cisplatin—bone cancer	0.00175	0.00177	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—bone cancer	0.00174	0.00177	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—bone cancer	0.00173	0.00175	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—bone cancer	0.00173	0.00175	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—bone cancer	0.00172	0.00174	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—bone cancer	0.00171	0.00173	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—bone cancer	0.00171	0.00173	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—bone cancer	0.00169	0.00171	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—bone cancer	0.00169	0.00171	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—bone cancer	0.00168	0.0017	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—bone cancer	0.00167	0.0017	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—bone cancer	0.00166	0.00168	CcSEcCtD
Gatifloxacin—Nausea—Cisplatin—bone cancer	0.00165	0.00167	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—bone cancer	0.00164	0.00166	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—bone cancer	0.00161	0.00163	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—bone cancer	0.00161	0.00163	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—bone cancer	0.0016	0.00162	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—bone cancer	0.00159	0.00161	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—bone cancer	0.00159	0.00161	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—bone cancer	0.00159	0.00161	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—bone cancer	0.00159	0.00161	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—bone cancer	0.00158	0.0016	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—bone cancer	0.00158	0.0016	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—bone cancer	0.00157	0.00159	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—bone cancer	0.00157	0.00159	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—bone cancer	0.00156	0.00158	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—bone cancer	0.00156	0.00158	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—bone cancer	0.00155	0.00157	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—bone cancer	0.00154	0.00156	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—bone cancer	0.00153	0.00155	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—bone cancer	0.00153	0.00155	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—bone cancer	0.00152	0.00154	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—bone cancer	0.00152	0.00154	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—bone cancer	0.00151	0.00153	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—bone cancer	0.00151	0.00153	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—bone cancer	0.00151	0.00152	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—bone cancer	0.00149	0.00151	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—bone cancer	0.00147	0.00149	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—bone cancer	0.00145	0.00147	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—bone cancer	0.00145	0.00147	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—bone cancer	0.00145	0.00147	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—bone cancer	0.00144	0.00145	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—bone cancer	0.00143	0.00144	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—bone cancer	0.00142	0.00144	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—bone cancer	0.00142	0.00144	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—bone cancer	0.00142	0.00144	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—bone cancer	0.00142	0.00144	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—bone cancer	0.00141	0.00143	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—bone cancer	0.0014	0.00142	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—bone cancer	0.0014	0.00142	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—bone cancer	0.00139	0.00141	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—bone cancer	0.00139	0.00141	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—bone cancer	0.00139	0.00141	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00139	0.0014	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—bone cancer	0.00138	0.00139	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—bone cancer	0.00137	0.00138	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—bone cancer	0.00136	0.00137	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—bone cancer	0.00136	0.00137	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—bone cancer	0.00135	0.00137	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—bone cancer	0.00134	0.00136	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—bone cancer	0.00133	0.00135	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—bone cancer	0.00133	0.00134	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—bone cancer	0.00132	0.00134	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—bone cancer	0.00131	0.00132	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.0013	0.00131	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—bone cancer	0.0013	0.00131	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—bone cancer	0.00129	0.00131	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—bone cancer	0.00129	0.0013	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—bone cancer	0.00129	0.0013	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—bone cancer	0.00128	0.00129	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—bone cancer	0.00127	0.00129	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—bone cancer	0.00127	0.00128	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—bone cancer	0.00127	0.00128	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—bone cancer	0.00126	0.00127	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—bone cancer	0.00125	0.00127	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—bone cancer	0.00125	0.00127	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—bone cancer	0.00124	0.00126	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—bone cancer	0.00124	0.00125	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—bone cancer	0.00123	0.00125	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—bone cancer	0.00122	0.00123	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—bone cancer	0.00121	0.00122	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—bone cancer	0.0012	0.00122	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—bone cancer	0.0012	0.00122	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0012	0.00121	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—bone cancer	0.00119	0.00121	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—bone cancer	0.00118	0.0012	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—bone cancer	0.00117	0.00119	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—bone cancer	0.00117	0.00119	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—bone cancer	0.00117	0.00119	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—bone cancer	0.00116	0.00118	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—bone cancer	0.00116	0.00117	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—bone cancer	0.00114	0.00116	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—bone cancer	0.00112	0.00113	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—bone cancer	0.00109	0.0011	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—bone cancer	0.00109	0.0011	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	0.00108	0.00109	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—bone cancer	0.00108	0.00109	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—bone cancer	0.00105	0.00106	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—bone cancer	0.00105	0.00106	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—bone cancer	0.00104	0.00105	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—bone cancer	0.00104	0.00105	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—bone cancer	0.00104	0.00105	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—bone cancer	0.00102	0.00103	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—bone cancer	0.00101	0.00102	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—bone cancer	0.00101	0.00102	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—bone cancer	0.000974	0.000986	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—bone cancer	0.00097	0.000982	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—bone cancer	0.000967	0.000979	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—bone cancer	0.000959	0.000971	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—bone cancer	0.000958	0.00097	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—bone cancer	0.000953	0.000965	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—bone cancer	0.000945	0.000957	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—bone cancer	0.000941	0.000953	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—bone cancer	0.000932	0.000943	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—bone cancer	0.000905	0.000916	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—bone cancer	0.000903	0.000915	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—bone cancer	0.000901	0.000912	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—bone cancer	0.000897	0.000909	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—bone cancer	0.000897	0.000908	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—bone cancer	0.000892	0.000903	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—bone cancer	0.000871	0.000882	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—bone cancer	0.000845	0.000856	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—bone cancer	0.000837	0.000848	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—bone cancer	0.00083	0.000841	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—bone cancer	0.00083	0.00084	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—bone cancer	0.000825	0.000835	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—bone cancer	0.000782	0.000792	CcSEcCtD
